CJC-1295 (No DAC) + Ipamorelin is a dual-peptide research blend frequently utilized in laboratory studies examining growth hormone (GH) signaling pathways. The combination is of interest in research settings due to the complementary mechanisms of action associated with each peptide.
CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog studied for its role in stimulating endogenous GH release without the prolonged activity associated with DAC-modified versions. Ipamorelin is a selective growth hormone secretagogue (GHS) commonly researched for its targeted interaction with GH-related receptors.
When combined, these peptides are often explored in short-acting, pulsatile GH research models, making the blend relevant for studies focused on timing-dependent hormone signaling and metabolic processes.
Common Areas of Research Interest
-
Growth hormone signaling mechanisms
-
Pulsatile GH release models
-
Cellular recovery and tissue repair research
-
Metabolic and body composition pathways
-
Age-related hormone signaling studies
All information provided is for educational and laboratory research purposes only and does not imply therapeutic use.
Reviews
There are no reviews yet.